Preventing Hepatitis C in Prisons: The Role of Opioid Agonist Treatment (OAT)

ASHM, in collaboration with the National Prisons Hepatitis Network, invites you to a free national Lunch & Learn webinar exploring the critical role of Opioid Agonist Treatment (OAT) in preventing hepatitis C (HCV) in correctional settings. Delivered by experts from across the country, the session features insights from the authors of the National Consensus Statement on OAT in custodial settings, alongside real-world experiences from New South Wales and Queensland correctional programs.

Designed for healthcare professionals, peer workers, policymakers, and anyone working to improve health in correctional settings.

Find out more by clicking the registration link and visiting the ASHM website!

Endorsement and CPD:
RACGP: Pending accreditation with RACGP. ASHM is an RACGP-accredited CPD Provider under the RACGP CPD Program.

Funding:
This event is supported by an unconditional education grant from Gilead Sciences. Sponsorship is provided in accordance with the ASHM’s Sponsorship Policy. ASHM does not endorse or promote any sponsor’s product or service.

For more information, contact ASHM Health at education@ashm.org.au or 0431320429.